论文信息 - Reply: To PMID 24486408. - 字舞流文

Reply: To PMID 24486408.

S. Vermeire | A. Gils | F. Baert

[1] P. Rutgeerts,et al. Early trough levels and antibodies to infliximab predict safety and success of reinitiation of infliximab therapy. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2] A. Cohen,et al. Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's disease. , 2014, Gastroenterology.

[3] P. Rutgeerts,et al. Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis. , 2014, Gastroenterology.

[4] P. Rutgeerts,et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. , 2010, The New England journal of medicine.

[5] M. Peppercorn,et al. Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial. , 2003, Gastroenterology.